-
The Role of Radiation Therapy for the Extramammary Paget's Disease of the Vulva ; Experience of 3 Cases
-
Seok-Hyun Son, Jung-Seok Lee, Yeon-Sil Kim, Mi-Ryeong Ryu, Su-Mi Chung, Sung-Eun Namkoong, Gu-Taek Han, Hee-Jeong Lee, Sei-Chul Yoon
-
Cancer Res Treat. 2005;37(6):365-369. Published online December 31, 2005
-
DOI: https://doi.org/10.4143/crt.2005.37.6.365
-
-
 Abstract
 PDF PubReader ePub
We have experienced three cases of extramammary Paget's disease (EMPD) of the vulva that received radiation therapy (RT). Here, we analyze the efficacy of RT and include a literature survey. Three patients with EMPD of the vulva were treated with curative RT between 1993 and 1998. One of the patients had associated underlying adenocarcinoma of the vulva. The total doses of radiation administered were 54~78 Gy/6~8 weeks. Radiation fields encompassed 2 to 3 cm outer margins free from all visible disease including or not including the inguinal area using a 9 MeV electron or a 6 MV photon beam. Follow-up durations after radiotherapy were 0.6~11 years. Complete response was obtained in all three patients. Marginal failure occurred in one patient, and another patient with underlying adenocarcinoma treated by vulvectomy with bilateral inguinal lymph node dissection followed by external RT showed no relapse. Radiation induced side effects were transient acute confluent wet desquamation in the treated area resulting in mild late atrophic skin changes. Although surgery is currently considered the preferred primary treatment for EMPD, it has a high relapse rate due to the multifocal nature of the disease. We conclude that RT is of benefit in some selected cases of EMPD. -
Citations
Citations to this article as recorded by  - Anatomic Subtype Differences in Extramammary Paget Disease
Nour Kibbi, Joshua L. Owen, Brandon Worley, Jake X. Wang, Vishnu Harikumar, Sumaira Z. Aasi, Sunandana Chandra, Jennifer N. Choi, Yasuhiro Fujisawa, Christos Iavazzo, John Y. S. Kim, Naomi Lawrence, Mario M. Leitao, Allan B. MacLean, Jeffrey S. Ross, Anth
JAMA Dermatology.2024; 160(4): 417. CrossRef - Vulvar Paget Disease: a series of cases in southern Brazil
Marcella B. Persiano, Elisa T. Rosin, Giovana A. Cabrera, Fernanda Uratani, Leticia V. Pires, Felipe Luzzatto, Kathleen M. Schmeler, Mila P. Salcedo
Journal of Global Health Reports.2023;[Epub] CrossRef - The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease
Michelle van der Linden, Colette L. van Hees, Marc van Beurden, Johan Bulten, Eleonora B. van Dorst, Martha D. Esajas, Kim A. Meeuwis, Dorry Boll, Mariëtte I. van Poelgeest, Joanne A. de Hullu
American Journal of Obstetrics and Gynecology.2022; 227(2): 250.e1. CrossRef - Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget’s Disease of the Vulva
Marina Stasenko, Gowtham Jayakumaran, Renee Cowan, Vance Broach, Dennis S. Chi, Anthony Rossi, Travis J. Hollman, Ahmet Zehir, Nadeem R. Abu-Rustum, Mario M. Leitao
JCO Precision Oncology.2020; (4): 1054. CrossRef - Invasive Vulval Paget’s disease treated with primary radiotherapy: A rare case report and literature review
Avir Sarkar, S.C. Saha, Pooja Sikka, Neha Kumari, Pranab Dey, Bhavana Rai
Gynecologic Oncology Reports.2020; 34: 100674. CrossRef - Nonsurgical Treatments for Extramammary Paget Disease: A Systematic Review and Meta-Analysis
Igor Snast, Eran Sharon, Ran Kaftory, Yehonatan Noyman, Meital Oren-Shabtai, Moshe Lapidoth, Emmilia Hodak, Daniel Mimouni, Sigal Mazor, Assi Levi
Dermatology.2020; 236(6): 493. CrossRef - A Rare Case of Recurrent Paget’s Disease of the Vulva and Gluteal Region Treated with Radiation Therapy
Mirza Athar Ali, M. Babaiah, Prabhakar Mariappan, Sudha Sinha, KR Muralidhar, Srinivas Ponaganti, Pranav Ashwin Shah, Sujana Priya Vuba, Arun Kumar Reddy Gorla, Deepak Koppaka
Applied Radiation Oncology.2020; : 44. CrossRef - Efficacy of low‐dose 5‐fluorouracil/cisplatin therapy for invasive extramammary Paget's disease
Hiroshi Kato, Shoichi Watanabe, Kiyonori Kariya, Motoki NAKAMURA, Akimichi Morita
The Journal of Dermatology.2018; 45(5): 560. CrossRef - The Role of Radiotherapy in Extramammary Paget Disease: A Systematic Review
L. Tagliaferri, C. Casà, G. Macchia, A. Pesce, G. Garganese, B. Gui, G. Perotti, S. Gentileschi, F. Inzani, R. Autorino, S. Cammelli, A.G. Morganti, V. Valentini, M.A. Gambacorta
International Journal of Gynecologic Cancer.2018; 28(4): 829. CrossRef - The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease
Michelle van der Linden, Kim Meeuwis, Colette van Hees, Eleonora van Dorst, Johan Bulten, Tjalling Bosse, Joanna IntHout, Dorry Boll, Brigitte Slangen, Manon van Seters, Marc van Beurden, Mariëtte van Poelgeest, Joanne de Hullu
JMIR Research Protocols.2017; 6(9): e178. CrossRef - Paget disease of the vulva
M. van der Linden, K.A.P. Meeuwis, J. Bulten, T. Bosse, M.I.E. van Poelgeest, J.A. de Hullu
Critical Reviews in Oncology/Hematology.2016; 101: 60. CrossRef - Primary extramammary invasive Paget’s vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?
Maria Tolia, Nikolaos Tsoukalas, Chrisostomos Sofoudis, Constantinos Giaginis, Despoina Spyropoulou, Dimitrios Kardamakis, Vasileios Kouloulias, George Kyrgias
BMC Cancer.2016;[Epub] CrossRef - Extramammary Paget Disease of the Vulva: Minimal Excision with Adjuvant Radiation Treatment for Optimal Aesthetic Results
Myeong Su Jeon, Gyu Yong Jung, Joon Ho Lee, Kyung Won Kang, Kwang Won No
Tumori Journal.2016; 102(2_suppl): S84. CrossRef - Paget Disease of the Vulva: Diagnosis by Immunohistochemistry
Andressa Gonçalves Amorim, Brunelle Batista Fraga Mendes, Rodrigo Neves Ferreira, Antônio Chambô Filho
Case Reports in Dermatological Medicine.2015; 2015: 1. CrossRef - Radiation therapy for extramammary Paget's disease: treatment outcomes and prognostic factors
M. Hata, I. Koike, H. Wada, E. Miyagi, T. Kasuya, H. Kaizu, T. Matsui, Y. Mukai, E. Ito, T. Inoue
Annals of Oncology.2014; 25(1): 291. CrossRef - Radiotherapy in Patients with Extramammary Paget's Disease - Our Own Experience and Review of the Literature
Tomohiro Itonaga, Hidetsugu Nakayama, Mitsuru Okubo, Ryuji Mikami, Sachica Nogi, Yu Tajima, Shinji Sugahara, Koichi Tokuuye
Oncology Research and Treatment.2014; 37(1-2): 18. CrossRef - Extramammary Paget's Disease of the Vulva: A Case Report and Review of the Literature
Nirmala Duhan, Mansi Juneja, Sunita Singh
Journal of Gynecologic Surgery.2013; 29(6): 297. CrossRef - HDR-plesiotherapy for the treatment of anogenital extramammary Paget's disease
Soraya Marcos, Angel Montero, Belén Capuz, Javier Martinez-Ollero, Raúl Hernanz, Eva Fernández, Alfredo Polo, Alfredo Ramos
Reports of Practical Oncology & Radiotherapy.2012; 17(3): 163. CrossRef - Extramammary Paget's disease treated with topical imiquimod 5% cream
Sue-Ann J. E. Ho, Derrick C. W. Aw
Dermatologic Therapy.2010; 23(4): 423. CrossRef
-
13,229
View
-
134
Download
-
19
Crossref
-
Immunization with Adenoviral Vectors Carrying Recombinant IL-12 and E7 Enhanced the Antitumor Immunity against Human Papillomavirus 16-associated Tumor
-
Eun-Kyung Park, Young-Wook Kim, Joon-Mo Lee, Sung-Eun NamKoong, Do-Gang Kim, Heung-Jae Chun, Byoung-Don Han, Su-Mi Bae, Hyun-Sun Jin, Jeong-Im Sin, Woong-Shick Ahn
-
Cancer Res Treat. 2005;37(1):63-70. Published online February 28, 2005
-
DOI: https://doi.org/10.4143/crt.2005.37.1.63
-
-
Abstract
PDFPubReaderePub
- Purpose
Human papillomavirus (HPV) infection has a significant role in cervical carcinogenesis, and HPV oncoprotein E7 plays an important part in the formation and maintenance of cervical cancer. Interleukin-12 (IL-12) has been reported to induce a cellular immune response, and to suppress the tumor growth and the E7 production. Here we describe the use of adenoviral delivery of the HPV 16 E7 subunit (AdE7) along with adenoviral delivery of IL-12 (AdIL-12) in mice with HPV-associated tumors. Materials and MethodsMice were injected with TC-1 cells to establish TC-1 tumor, and then they were immunized with AdIL-12 and/or AdE7 intratumorally. The anti tumor effects induced by AdIL-12 and/or E7 were evaluated by measuring the size of the tumor. E7-specific antibody and INF-γ production in sera, and the T-helper cell proliferative responses were then measured. Cytotoxic T-lymphocyte (CTL) and T cell subset depletion studies were also performed. ResultsCombined AdIL-12 and AdE7 infection at the tumor sites significantly enhanced the antitumor effects more than that of AdIL-12 or AdE7 single infection. This combined infection resulted in regression of the 9 mm sized tumors in 80% of animals as compare to the PBS group. E7-specific antibody and INF-γ production in the sera, and the T-helper cell proliferative responses were significantly higher with coinfection of AdIL-12 and AdE7 than with AdIL-12 or AdE7 alone. CTL response induced by AdIL-12 and AdE7 in the coinjected group suggested that tumor suppression was mediated by mostly CD8+ and only a little by the CD4+ T cells. ConclusionIL-12 and E7 application using adenovirus vector showed antitumor immunity effects against TC-1 tumor, and this system could be use in clinical applications for HPV-associated cancer. (ED note: nice abstract.)
-
Citations
Citations to this article as recorded by - Development of a replication‐deficient adenoviral vector‐based vaccine candidate for the interception of HPV16‐ and HPV18‐induced infections and disease
Selina Khan, Koen Oosterhuis, Kerstin Wunderlich, Evelien M. Bunnik, Melissa Bhaggoe, Satish Boedhoe, Santusha Karia, Renske D.M. Steenbergen, Leontien Bosch, Jan Serroyen, Sarah Janssen, Hanneke Schuitemaker, Jort Vellinga, Gert Scheper, Roland Zahn, Jer
International Journal of Cancer.2017; 141(2): 393. CrossRef - Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs
Jiarong Xu, Dongyan Huang, shichao Liu, Huixing Lin, Haodan Zhu, Bao Liu, Chengping Lu
Vaccine.2012; 30(20): 3119. CrossRef - Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs
Jiarong Xu, Dongyan Huang, Shichao Liu, Huixing Lin, Haodan Zhu, Bao Liu, Chengping Lu
Virus Research.2012; 167(2): 188. CrossRef
-
8,626
View
-
37
Download
-
3
Crossref
-
Proteome Analysis of Differential Protein Expression in Cervical Cancer Cells after Paclitaxel Treatment
-
Eun-Kyoung Yim, Jun-Sang Bae, Seung-Bak Lee, Keun-Ho Lee, Chan-Joo Kim, Sung-Eun Namkoong, Soo-Jong Um, Jong-Sup Park
-
Cancer Res Treat. 2004;36(6):395-399. Published online December 31, 2004
-
DOI: https://doi.org/10.4143/crt.2004.36.6.395
-
-
Abstract
PDFPubReaderePub
- Purpose
It is well known that infection with HPV (human papillomavirus) is the main cause of cervical cancer and certain types of HPV are recognized as carcinogens. At present, there is little information regarding the antineoplastic mechanism of paclitaxel against cervical carcinoma cells. We thus tried to analyze differential protein expression and antineoplastic mechanism-related proteins after paclitaxel treatment on cervical cancer cells by using a proteomic analysis and to investigate the mechanism of action. Materials and MethodsUsing proteomics analysis including 2-DE and MALDI-TOF-MS, we detected the antineoplastic mechanism-related proteins. Then, we performed western blot analysis for apoptosis- and transformation-related proteins to confirm expression patterns derived from proteome analysis after paclitaxel treatment. ResultsWe identified several cellular proteins that are responsive to paclitaxel treatment in HeLa cells using proteomics methods. Paclitaxel treatment elevated mainly apoptosis, immune response and cell cycle check point-related proteins. On the other hand, paclitaxel treatment diminished growth factor/oncogene-related proteins and transcription regulation-related proteins. Also, in the HPV-associated cervical carcinoma cells, paclitaxel demonstrated anti-proliferative activity through the membrane death receptor-mediated apoptotic pathway and the mitochondrial-mediated pathway. ConclusionIdentification and characterization of functionally modulated proteins involved in anti-cancer regulatory events should lead to a better understanding of the long-term actions of paclitaxel at the molecular level and will contribute to the future development of novel therapeutic drug treatments based upon current therapies.
-
Citations
Citations to this article as recorded by - Proteomic Analysis of Thermus thermophilus Cells after Treatment with Antimicrobial Peptide
Alexey K. Surin, Anna I. Malykhina, Michail V. Slizen, Alexey P. Kochetov, Mariya Yu. Suvorina, Vadim E. Biryulyov, Sergei Y. Grishin, Oxana V. Galzitskaya
Bacteria.2024; 3(4): 299. CrossRef - Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring
Georgia Kontostathi, Jerome Zoidakis, Nicholas P. Anagnou, Kalliopi I. Pappa, Antonia Vlahou, Manousos Makridakis
Expert Review of Proteomics.2016; 13(8): 731. CrossRef - PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
Haiyan Zhu, Jun Wu, Wenwen Zhang, Hui Luo, Zhaojun Shen, Huihui Cheng, Xueqiong Zhu
Scientific Reports.2016;[Epub] CrossRef - Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria
Yang Wang, Ru-Yuan Yu, Qing-Yu He
Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1. CrossRef - Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture
Debasish Paul, Avinash Kumar, Akshada Gajbhiye, Manas K. Santra, Rapole Srikanth
BioMed Research International.2013; 2013: 1. CrossRef - Identification of Cervical Cancer Proteins Associated With Treatment With Paclitaxel and Cisplatin in Patients
Huiling Liu, Yin Han, Ruoran Mi, Ying Zhang, Gang Su, Hailin Wang, Xin Zhou, Xiangwen Liu, Bingdong Zhu
International Journal of Gynecological Cancer.2011; 21(8): 1452. CrossRef - Impact of taxol on dermal papilla cells — A proteomics and bioinformatics analysis
Pei-Hsiu Chen, Chih-Yuan Wang, Ching-Wu Hsia, Ming-Yi Ho, Ann Chen, Min-Jen Tseng, Yung-Fu Wu, Han-Min Chen, Tzu-Hao Huang, Hung-Te Liu, Hao-Ai Shui
Journal of Proteomics.2011; 74(12): 2760. CrossRef
-
10,490
View
-
64
Download
-
7
Crossref
-
Photodynamic Effects of Radachlorin® on Cervical Cancer Cells
-
Su-Mi Bae, Yong-Wook Kim, Joon-Mo Lee, Sung-Eun Namkoong, Sei-Jun Han, Jong-Ki Kim, Chang-Hee Lee, Heung-Jae Chun, Hyun-Sun Jin, Woong-Shick Ahn
-
Cancer Res Treat. 2004;36(6):389-394. Published online December 31, 2004
-
DOI: https://doi.org/10.4143/crt.2004.36.6.389
-
-
Abstract
PDFPubReaderePub
- Purpose
Photodynamic therapy (PDT) is a novel treatment modality, which produces local tissue necrosis with laser light following the prior administration of a photosensitizing agent. Radachlorin® has recently been shown to be a promising PDT sensitizer. In order to elucidate the antitumor effects of PDT using Radachlorin® on cervical cancer, growth inhibition studies on a HPV-associated tumor cell line, TC-1 cells in vitro and animals with an established TC-1 tumor in vivo were determined. Materials and MethodsTC-1 tumor cells were exposed to various concentrations of Radachlorin® and PDT, with irradiation of 12.5 or 25 J/cm2 at an irradiance of 20 mW/cm2 using a Won-PDT D662 laser at 662 nm in vitro. C57BL/6 mice with TC-1 tumor were injected with Radachlorin® via different routes and treated with PDT in vivo. A growth suppression study was then used to evaluate the effects at various time points after PDT. ResultsThe results showed that irradiation of TC-1 tumor cells in the presence of Radachlorin® induced significant cell growth inhibition. Animals with established TC-1 tumors exhibited significantly smaller tumor sizes over time when treated with Radachlorin® and irradiation. ConclusionPDT after the application of Radachlorin® appears to be effective against TC-1 tumors both in vitro and in vivo.
-
Citations
Citations to this article as recorded by - Photodynamic therapy: Innovative approaches for antibacterial and anticancer treatments
Marketa Kolarikova, Barbora Hosikova, Hanna Dilenko, Katerina Barton‐Tomankova, Lucie Valkova, Robert Bajgar, Lukas Malina, Hana Kolarova
Medicinal Research Reviews.2023; 43(4): 717. CrossRef - Applications of Photodynamic Therapy in Endometrial Diseases
Gabriela Correia-Barros, Beatriz Serambeque, Maria João Carvalho, Carlos Miguel Marto, Marta Pineiro, Teresa M. V. D. Pinho e Melo, Maria Filomena Botelho, Mafalda Laranjo
Bioengineering.2022; 9(5): 226. CrossRef - Photodynamic treatment with purpurin 18 effectively inhibits triple negative breast cancer by inducing cell apoptosis
Pengyun Huang, Baoting Zhang, Qiuju Yuan, Xie Zhang, Wingnang Leung, Chuanshan Xu
Lasers in Medical Science.2021; 36(2): 339. CrossRef - Assessing of integration of ionizing radiation with Radachlorin-PDT on MCF-7 breast cancer cell treatment
R. Ghoodarzi, V. Changizi, A. R. Montazerabadi, N. Eyvazzadaeh
Lasers in Medical Science.2016; 31(2): 213. CrossRef - Chlorophyll a Covalently Bonded to Organo-Modified Translucent Silica Xerogels: Optimizing Fluorescence and Maximum Loading
M. García-Sánchez, I. Serratos, R. Sosa, T. Tapia-Esquivel, F. González-García, F. Rojas-González, S. Tello-Solís, A. Palacios-Enriquez, J. Esparza Schulz, A. Arrieta
Molecules.2016; 21(7): 961. CrossRef - Evaluation of Silicon Phthalocyanine 4 Photodynamic Therapy against Human Cervical Cancer Cells <i>in Vitro</i> and in Mice
Jill A. Gadzinski, Jianxia Guo, Brian J. Philips, Per Basse, Ethan K. Craig, Lisa Bailey, Joseph Latoche, John T. Comerci, Julie L. Eiseman
Advances in Biological Chemistry.2016; 06(06): 193. CrossRef - Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors
Jan Willem Kleinovink, Pieter B. van Driel, Thomas J. Snoeks, Natasa Prokopi, Marieke F. Fransen, Luis J. Cruz, Laura Mezzanotte, Alan Chan, Clemens W. Löwik, Ferry Ossendorp
Clinical Cancer Research.2016; 22(6): 1459. CrossRef - Photodynamic therapy: An adjunct to conventional root canal disinfection strategies
Shipra Singh, Rajni Nagpal, Naveen Manuja, Sashi Prabha Tyagi
Australian Endodontic Journal.2015; 41(2): 54. CrossRef - The efficacy of Radachlorin-mediated photodynamic therapy in human hepatocellular carcinoma cells
Hamidreza Mirzaei, Gholamreza Esmaeeli Djavid, Mahnaz Hadizadeh, Maryam Jahanshiri-Moghadam, Parastoo Hajian
Journal of Photochemistry and Photobiology B: Biology.2015; 142: 86. CrossRef - Chlorin e6 Derivative Radachlorin Mainly Accumulates in Mitochondria, Lysosome and Endoplasmic Reticulum and Shows High Affinity toward Tumors in Nude Mice in Photodynamic Therapy
Raktim Biswas, Jeong Hwan Moon, Jin‐Chul Ahn
Photochemistry and Photobiology.2014; 90(5): 1108. CrossRef - Microscopic analysis of the localization of two chlorin‐based photosensitizers in OSC19 tumors in the mouse oral cavity
Floor van Leeuwen–van Zaane, Pieter B.A.A. van Driel, Ute A. Gamm, Thomas J.A. Snoeks, Henriëtte S. de Bruijn, Angelique van der Ploeg–van den Heuvel, Clemens W.G.M. Löwik, Henricus J.C.M. Sterenborg, Arjen Amelink, Dominic J. Robinson
Lasers in Surgery and Medicine.2014; 46(3): 224. CrossRef - Photodynamic effect of Radachlorin on nerve and glial cells
M.A. Neginskaya, E.V. Berezhnaya, M.V. Rudkovskii, S.V. Demyanenko, A.B. Uzdensky
Photodiagnosis and Photodynamic Therapy.2014; 11(3): 357. CrossRef - Development of radiolabeled radachlorin complex as a possible tumor targeting agent
Yousef Fazaeli, Amir R. Jalilian, Fatemeh Rezaee, Tahereh Firouzyar, Sedigheh Moradkhani, Azar Bagheri, Abbas Majdabadi
Journal of Radioanalytical and Nuclear Chemistry.2014;[Epub] CrossRef - Fluorescence optimization of chlorophyll covalently bonded to mesoporous silica synthesized by the sol–gel method
I.N. Serratos, F. Rojas-González, R. Sosa-Fonseca, J.M. Esparza-Schulz, V. Campos-Peña, S.R. Tello-Solís, M.A. García-Sánchez
Journal of Photochemistry and Photobiology A: Chemistry.2013; 272: 28. CrossRef - Efficacy and Safety of Photodynamic Therapy for Recurrent, High Grade Nonmuscle Invasive Bladder Cancer Refractory or Intolerant to Bacille Calmette-Guérin Immunotherapy
Joo Yong Lee, Richilda Red Diaz, Kang Su Cho, Meng Shi Lim, Jae Seung Chung, Won Tae Kim, Won Sik Ham, Young Deuk Choi
Journal of Urology.2013; 190(4): 1192. CrossRef - Crossed and Linked Histories of Tetrapyrrolic Macrocycles and Their Use for Engineering Pores within Sol-Gel Matrices
Miguel García-Sánchez, Fernando Rojas-González, E. Menchaca-Campos, Salvador Tello-Solís, R. Quiroz-Segoviano, Luis Diaz-Alejo, Eduardo Salas-Bañales, Antonio Campero
Molecules.2013; 18(1): 588. CrossRef - Photodynamic Therapy for Recurrent Head and Neck Malignancy
Yong-Sik Lee, Young-Chang Lim, Yeo-Jin Lee, Mun-Su Park, Jae-Myeong Kim
Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2011; 54(4): 271. CrossRef - Evaluation of the effect of photoactivated disinfection with Radachlorin® against Streptococcus mutans (an in vitro study)
Reza Fekrazad, Majid Bargrizan, Sepideh Sajadi, Soodabeh Sajadi
Photodiagnosis and Photodynamic Therapy.2011; 8(3): 249. CrossRef - In vitro evaluation of Radachlorin® sensitizer for photodynamic therapy
Samuel Douillard, Isabelle Lhommeau, David Olivier, Thierry Patrice
Journal of Photochemistry and Photobiology B: Biology.2010; 98(2): 128. CrossRef - In vitro and in vivo evaluation of Radachlorin® sensitizer for photodynamic therapy
Samuel Douillard, David Olivier, Thierry Patrice
Photochemical & Photobiological Sciences.2009; 8(3): 405. CrossRef - Role of Microarray in Cancer Diagnosis
Hoguen Kim
Cancer Research and Treatment.2004; 36(1): 1. CrossRef
-
11,644
View
-
69
Download
-
21
Crossref
|
KCA
